CompletedPhase 3NCT01410474

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

Studying Meningococcal meningitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Novartis
Principal Investigator
Li Min Huang, Dr.
Dr. Li Min Huang, National Taiwan University Hospital
Intervention
Meningococcal ACWY conjugate vaccine(biological)
Enrollment
341 target
Eligibility
2-18 years · All sexes
Timeline
2011 – 2012

Study locations (3)

Collaborators

Novartis Vaccines

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01410474 on ClinicalTrials.gov

Other trials for Meningococcal meningitis

Additional recruiting or active studies for the same condition.

See all trials for Meningococcal meningitis →

← Back to all trials